Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Evaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertension.

Bauman DR, Whitehead A, Contino LC, Cui J, Garcia-Calvo M, Gu X, Kevin N, Ma X, Pai LY, Shah K, Shen X, Stribling S, Zokian HJ, Metzger J, Shevell DE, Waddell ST.

Bioorg Med Chem Lett. 2013 Jun 15;23(12):3650-3. doi: 10.1016/j.bmcl.2013.03.011. Epub 2013 Mar 22.

PMID:
23659858
2.

Characterization of neuromedin U effects in canine smooth muscle.

Westfall TD, McCafferty GP, Pullen M, Gruver S, Sulpizio AC, Aiyar VN, Disa J, Contino LC, Mannan IJ, Hieble JP.

J Pharmacol Exp Ther. 2002 Jun;301(3):987-92.

3.

The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.

Abrahamsen CT, Barone FC, Campbell WG Jr, Nelson AH, Contino LC, Pullen MA, Grygielko ET, Edwards RM, Laping NJ, Brooks DP.

J Pharmacol Exp Ther. 2002 Apr;301(1):21-8.

4.

Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.

Wong VY, Laping NJ, Nelson AH, Contino LC, Olson BA, Gygielko E, Campbell WG Jr, Barone F, Brooks DP.

Br J Pharmacol. 2001 Nov;134(5):977-84.

5.

Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.

Barone FC, Coatney RW, Chandra S, Sarkar SK, Nelson AH, Contino LC, Brooks DP, Campbell WG Jr, Ohlstein EH, Willette RN.

Cardiovasc Res. 2001 Jun;50(3):525-37.

PMID:
11376628
6.

Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failure.

Edwards RM, Contino LC, Gellai M, Brooks DP.

Pharmacology. 2001 May;62(4):243-7.

PMID:
11360002
7.

Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan.

Wong VY, Laping NJ, Contino LC, Olson BA, Grygielko E, Brooks DP.

Physiol Genomics. 2000 Nov 9;4(1):35-42.

PMID:
11074011
8.

Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.

Ali SM, Laping NJ, Fredrickson TA, Contino LC, Olson Ba, Anderson K, Brooks DP.

Pharmacology. 1998 Jul;57(1):20-7.

PMID:
9670209
9.

Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reduction.

Olson BA, Ali SM, Contino LC, Brooks DP, Laping NJ.

Pharmacology. 1998 Jul;57(1):13-9.

PMID:
9670208
10.
11.

The age-related increase in renal clusterin mRNA is accelerated in obese Zucker rats.

Laping NJ, Olson BA, Day JR, Brickson BM, Contino LC, Short BG, Ali SM, Brooks DP.

J Am Soc Nephrol. 1998 Jan;9(1):38-45.

12.

Phosphate excretion and phosphate transporter messenger RNA in uremic rats treated with phosphonoformic acid.

Brooks DP, Ali SM, Contino LC, Stack E, Fredrickson TA, Feild J, Edwards RM.

J Pharmacol Exp Ther. 1997 Jun;281(3):1440-5.

13.
14.

SB 203220: a novel angiotensin II receptor antagonist and renoprotective agent.

Brooks DP, Contino LC, Short BG, Gowan C, Trizna W, Edwards RM.

J Pharmacol Exp Ther. 1995 Sep;274(3):1222-7.

PMID:
7562492
15.

Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.

Brooks DP, Short BG, Cyronak MJ, Contino LC, DiCristo M, Wang YX, Ruffolo RR Jr.

Br J Pharmacol. 1993 Jun;109(2):581-6.

16.

Increased endothelin excretion in rats with renal failure induced by partial nephrectomy.

Brooks DP, Contino LC, Storer B, Ohlstein EH.

Br J Pharmacol. 1991 Dec;104(4):987-9.

17.

Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number.

Brooks DP, Ohlstein EH, Contino LC, Storer B, Pullen M, Caltabiano M, Nambi P.

Eur J Pharmacol. 1991 Feb 26;194(1):115-7.

PMID:
1647960
18.

Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity.

Nambi P, Pullen M, Contino LC, Brooks DP.

Eur J Pharmacol. 1990 Oct 2;187(1):113-6.

PMID:
2176978
19.

Vasopressin and the pathogenesis of chronic renal failure.

Brooks DP, Solleveld HA, Contino LC.

Br J Pharmacol. 1990 May;100(1):79-82.

20.

Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablation.

Brooks DP, Contino LC, Trizna W, Edwards RM, Ohlstein EH, Solleveld HA.

J Pharmacol Exp Ther. 1990 Apr;253(1):119-23.

PMID:
2139468
21.

Rat kidney mitochondrial carbonic anhydrase.

Dodgson SJ, Contino LC.

Arch Biochem Biophys. 1988 Jan;260(1):334-41.

PMID:
3124750

Supplemental Content

Loading ...
Support Center